S.No. |
Title of the study |
Name of Researcher |
1. |
A randomised double blind, placebo-controlled study to evaluate the long-term safety and efficacy of Darbepoetin Alfa administered at 500 µg once-every-3-weeks to a hemoglobin ceiling of 12.0 g/dl in anemic subjects with advanced stage non-small cell lung cancer receiving multicycle chemotherapy |
Dr. D. Behera, Dr. A. Jaiswal, Dr. Rajnish Gupta, Dr. J.K.Saini |
2. |
A phase 2, multicenter, open label, randomized trial of AMG 706 or Bevacizumab in combination with Paclitaxel and Carboplatin for advanced non squamous Non-small Cell lung Cancer |
Dr. D. Behera, Dr. A. Jaiswal |
3. |
Study A4021016 Randomized open label, Phase III Trial of CP-751,871 in combination with paclitaxel and carboplatin versus paclitaxel and carboplatin in patients with non- small cell lung cancer |
Dr. D. Behera, Dr. A. Jaiswal, Dr. Lokender |
4. |
Annual Risk of Tuberculosis Infection (ARTI) in the slum population covered under RNTCP by National Institute of TB & RD |
Dr. Rohit Sarin, Dr. D. Behera, Dr. Vikram Vohra, Dr. Khalid U.K. |
5. |
Efficacy and safety of Immunomodulator (Mw) in Cat.II Pulmonary TB patients (Collaboration with DBT) |
Dr. Rohit Sarin, Dr Neeta Singla |
6. |
Repeat zonal level tuberculin survey for estimating annual risk of tuberculosis infection in East Zone (collaboration with NTI Bangalore) |
Dr. Rohit Sarin, Dr. V. Vohra, Dr. Khalid U.K. |
7. |
Molecular characterization of mycobacterium tuberculosis isolates from seven states of North-East India using spoligotyping |
Dr. V.P. Myneedu, Dr. D. Behera, Dr. M. Bhalla, Dr. Ritu Singhal, Dr. Niti Singh |
8. |
Prevalence of multi-drug resistant mycobacterium tuberculosis in North-East states, Delhi and Punjab using Line-probe assay in various subsets of RNTCP patients. |
Dr. V.P. Myneedu, , Dr. Ritu Singhal, Dr. D. Behera, Dr. Niti Singh, Dr. Jyoti Arora, Dr. M. Bhalla |
9. |
Role of voltage gated calcium channels and Suppressors of Cytokine Signaling (SOCS) in regulating immune responses to Mycobacterium tuberculosis (collaboration with ICGEB). |
Dr K. Natarajan, Dr R. Singla, Dr Khalid U.K. |
10. |
Identification of biomarkers and pathogen regulated targets for tuberculosis infection (collaboration with ICGEB). |
Prof. V.S. Chauhan, Dr. D. Behera, Dr. R. Singla, Dr Khalid U.K. |
11. |
Functional analysis of IL – 12R mutation in tuberculosis. |
Dr. Anand Jaiswal, Dr. D. Behera, Dr. Sangeeta Sharma, Dr. J S Tyagi, Mr. Vikas Kumar Sharma, Dr. H. Krishna Prasad |
12. |
To study interleukin – 12 and its receptor polymorphism in TB patient and controls. |
Dr. Anand Jaiswal, Dr. D. Behera, Dr. Sangeeta Sharma, Dr. J S Tyagi, Dr. Rajiv Kr. Jha, Dr. H. Krishna Prasad |
13. |
Profile of tuberculosis among house hold contacts of MDR tuberculosis registered under DOTS Plus (Central TB Division funded) |
Dr. Neeta Singla, Dr. D. Behera, Dr. R. Singla, Dr. P. Visalakshi |
14. |
Deciphering dendritic cell function during Mycobacterium tuberculosis infection by RNA interference (in collaboration with Dr. B R Ambedkar Centre for Biomedical Research, University of Delhi) |
Dr. Rupak Singla, Dr. D. Behera, Dr. K. Natarajan, Dr. Neeta Singla |
15. |
Delays and constraints in diagnosis and initiation of DOTS-Plus treatment in MDR-TB patients at a DOTS Plus site, Delhi |
Dr. Neeta Singla, Dr. D. Behera, Dr. Rupak Singla, Dr. P. Visalakshi |
16. |
A study on smoking behaviour, attributable risk of smoking to pulmonary tuberculosis and efficacy of smoking cessation among tuberculosis patients |
Dr. Neeta Singla, Dr. D. Behera, Dr. Somdatta Patra, Dr S.B.Singh, Dr. G. R. Khatri |
17. |
Evaluation and diabetes as determinant of tuberculosis : A matched controlled study |
Dr. Neeta Singla, Dr. Rajendra Tandon, Dr. D. Behera, Dr. Roopa S |
18. |
Study of Adverse of Adverse Drug Reaction in MDR TB patients under DOTS plus program (2011) |
Dr. Neeta Singla, Dr. Rupak Singla, Mr. Anurag Gautam, Dr. D. Behera |
19. |
Radiological pattern in Pulmonary TB in Children |
Dr. Sangeeta Sharma, Dr. Anita Yadav |
20. |
To study HIV status of pediatric Pulmonary & Extra Pulmonary patients |
Dr. Sangeeta Sharma, Dr S.K. Munjal |
21. |
To study the menstrual pattern of adolescent girls in pulmonary & extra-pulmonary TB |
Dr. Sangeeta Sharma |
22. |
To study the association of indoor environmental risk factors and childhood tuberculosis |
Dr. D. Behera, Dr. Sangeeta Sharma, Dr. Somdatta Patra |
23. |
Surveillance of drug resistance at LSRI TB & RD New Delhi DOTS Area |
Dr. V.P. Myneedu, Dr Ritu Singhal, Dr M. Bhalla, Dr Khalid U.K., Mr P.P.Sharma |
24. |
Profile of Mycobacterium tuberculosis at NITBRD – A retrospective study |
Dr V.P.Myneedu |
25. |
Evaluation of real time PCR for the diagnosis of pulmonary and extra-pulmonary specimens and its comparison with conventional IS6110 PCR, MGIT 960 TB system, conventional culture & Smear Microscopy |
Dr D. Behera, Dr M. Bhalla, Dr Jyoti Arora, Dr Tamanna Sharma |
26. |
Study the impact of TB on HIV activity in dually infected patients using RT-PCR Assay |
Dr Tamanna Sharma, Dr. M. Bhalla, Dr. Upasana Agarwal |
27. |
Utility of PCR for diagnosis of pulmonary and extra pulmonary TB in comparison with smear microscopy, conventional culture and MGIT 960 system |
Dr. M. Bhalla, Dr Tamanna Sharma, Dr. D. Behera, Dr Jyoti Arora |
28. |
Evaluation of performance and suitability of Light Emitting Diode (LED) fluorescence microscope for detection of Acid Fast Bacilli in sputum for tuberculosis diagnosis (Funded by OLMPUS Magnus analyticus) |
Dr. M. Bhalla, Dr P.P.Sharma |
29. |
Studies on Aspergillus fumigatus proteome for identification of novel unknown immunogens |
Dr. D. Behera, Dr. J.K. Saini, Dr. G.L. Sharma |
30. |
Molecular analysis of MDR and XDR strains of Mycobacterium tuberculosis isolated from a tertiary care hospital (ICMR funded) |
Dr Urvashi B.Singh, Dr. D. Behera, Dr Jyoti Arora, Dr. M. Bhalla |
31. |
Validation and clinical studies for methods for diagnosis of tuberculosis by smear microscopy, culture and polymerase chain reaction using processed clinical samples and kit thereof (DBT funded) |
Dr. M. Bhalla, Dr Jaya Tyagi |
32. |
Study of the influence of stress and micro-nutrients deficiency on human immuno-competent cells and its implication to mycobacterium tuberculosis |
Dr. H.K. Prasad, Ms Savita Singh, Dr. D. Behera, Dr Anand Jaiswal |
33. |
Use of the BACTEC Mycobacteria Growth Indicator Tube 960 Automated System for recovery of mycobacteria from extrapulmonary specimens and typing of isolates using Spoligotyping |
Dr. M. Bhalla, Dr. Jyoti Arora,
Dr. D. Behera |
34. |
Tobacco consumption in youth attending OPD in a tertiary care respiratory hospital in Delhi. |
Dr. Sujata Arya, Dr. Khalid U. K., Dr. D. Behera |
35. |
To study the feasibility and usefulness of multiple samples collected same day for smear microscopy in the diagnosis of pulmonary TB at NITBRD |
Dr. Ajoy Kumar Verma, Dr. V.P. Myneedu |
36. |
Evaluation and justification of phenol-Ammonium sulphate precipitation / sedimentation smear microscopy method for diagnosis of pulmonary tuberculosis : an effective, safe and reliable alternative for direct smear microscopy in microscopy centers |
Dr. Ritu Singhal, Dr. M. Bhalla, Dr. V. P. Myneedu, Dr. D. Behera |
37. |
Molecular epidemiology and genetic characterization of M. tuberculosis from HIV seronegative and HIV seropositive patients |
Dr. Niti Singh, Dr. D. Behera, Dr. Tamanna Sharma, Prof.Sarman Singh |
38. |
Role of modifications in routine fine needle aspiration cytology for increasing the diagnostic yield in extra-pulmonary tuberculosis |
Dr. Shalini Mullick, Dr. Nidhi Paliwal, Dr. Sapna Thakur, Dr. Kumud Gupta |
39. |
Molecular epidemiology of Extensively Drug Resistant TB (XDR-TB)and development of a rapid diagnostic technique. |
Chhavi Gupta, Dr. Rupak Singla |
40. |
Identification & evaluation ofMycobacterium tuberculosisantigens as biomarkers in clinical samples from tuberculosis patients & comparative analysis with other diagnostic methods |
Amit Kaushik, Dr. Rupak Singla |
41. |
A study to assess the need for training of nurses regarding management of TB patients receiving DOTS and DOTS Plus under RNTCP in selected hospitals and outreach facilities in Delhi |
Mrs. Anita Kansal, Dr. D. Behera, Dr. R. Mahal |
42. |
What is time taken and reasons for delay in the diagnosis and treatment in patients with lung cancer attending a tertiary care hospital in Delhi? |
Dr. J.K. Saini, Dr D. Behera, Dr. Anand Jaiswal |
43. |
Synergistic drug medium of INH and Rifampicin for identification of MDR Mycobacterium tuberculosis |
Manoj Kumar, Dr M. Bhalla, Dr. Ritu Singhal |
44. |
Study of the modulation of cell surface receptors by mycobacterium and defined recombinant antigens in human immune-competent cells and its functional significance |
Ms. Harshita Mittal, Dr. S.K. Munjal |
45. |
Effects of high intensity interval based inspiratory muscle training in patients with COPD undergoing a 4 weeks Pulmonary Rehabilitaion Programme on PFT values (FEV1/FVC), Peak inspiratory pressures, dyspnea score, functional capacity and HQRL |
Mr. Sumanta Ghosh, Dr. S.K. Munjal |
46. |
Comparative effects of chair sitting and forward lean with cross legged sitting position on Cardio Respiratory parameters during recovery after six minute walk test in COPD patients |
Md. Mumtaz Uddin, Dr. S.K. Munjal |
47. |
“Comparison of effect of flow oriented versus volume oriented incentive spirometry on PFT, chest expansion, exercise tolerance, Dyspnea and Quality of life in Post Tuberculous Empyema Thoracis” |
Mr. Akmal Aslam Kothawala, Dr. S.K. Munjal |